EGI
CRMD icon

EAM Global Investors’s CorMedix CRMD Stock Holding History

EAM Global Investors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-249,343
Closed -$3.07M – 27
2025
Q2 		$3.07M Buy
+249,343
New +$2.75M 0.8% 72
2019
Q2 		– Sell
-99,437
Closed -$940K – 137
2019
Q1 		$940K Buy
+99,437
New +$896K 0.42% 114

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EAM Global Investors's CRMD Position: Q3 2025 in Review

EAM Global Investors sold out of CorMedix (CRMD) in Q3 2025, closing a stake of 249,343 shares — an estimated $3.07M sold.

EAM Global Investors first reported a position in CRMD in Q1 2019 and held it in 2 quarters. The position peaked at $3.07M in Q2 2025. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

  • EAM Global Investors reported no remaining CorMedix position as of Q3 2025 after selling out during the quarter.
  • EAM Global Investors sold 249,343 CorMedix shares in Q3 2025, an estimated $3.07M.
  • EAM Global Investors first reported a position in CorMedix in Q1 2019 and held it in 2 quarters.
  • EAM Global Investors's CorMedix position peaked at $3.07M in Q2 2025.
  • 190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on EAM Global Investors's 13F filing for Q3 2025, filed 14 Nov 2025.